Metropolitan Life Insurance Company (MetLife)’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,757
| Closed | -$4.05M | – | 546 |
|
|
2024
Q1 | $4.05M | Sell |
50,757
-1,524
| -3% | -$116K | 0.18% | 104 |
|
|
2023
Q4 | $4.13M | Sell |
52,281
-860
| -2% | -$61.2K | 0.19% | 94 |
|
|
2023
Q3 | $3.71M | Sell |
53,141
-2,728
| -5% | -$193K | 0.19% | 94 |
|
|
2023
Q2 | $3.86M | Sell |
55,869
-1,566
| -3% | -$111K | 0.19% | 98 |
|
|
2023
Q1 | $4.27M | Sell |
57,435
-18,563
| -24% | -$1.56M | 0.22% | 89 |
|
|
2022
Q4 | $7.08M | Sell |
75,998
-2,162
| -3% | -$209K | 0.32% | 65 |
|
|
2022
Q3 | $7.45M | Sell |
78,160
-822
| -1% | -$81.4K | 0.35% | 51 |
|
|
2022
Q2 | $7.32M | Sell |
78,982
-2,015
| -2% | -$197K | 0.32% | 61 |
|
|
2022
Q1 | $8.2M | Sell |
80,997
-69,840
| -46% | -$7.34M | 0.29% | 65 |
|
|
2021
Q4 | $15.6M | Sell |
150,837
-4,326
| -3% | -$400K | 0.21% | 80 |
|
|
2021
Q3 | $13.2M | Sell |
155,163
-4,964
| -3% | -$416K | 0.19% | 94 |
|
|
2021
Q2 | $13.4M | Sell |
160,127
-1,808
| -1% | -$148K | 0.19% | 96 |
|
|
2021
Q1 | $12.2M | Sell |
161,935
-7,719
| -5% | -$562K | 0.18% | 95 |
|
|
2020
Q4 | $11.6M | Sell |
169,654
-9,004
| -5% | -$586K | 0.17% | 94 |
|
|
2020
Q3 | $10.4M | Sell |
178,658
-7,697
| -4% | -$479K | 0.18% | 96 |
|
|
2020
Q2 | $12.1M | Sell |
186,355
-10,438
| -5% | -$657K | 0.21% | 85 |
|
|
2020
Q1 | $11.7M | Sell |
196,793
-752
| -0.4% | -$50.2K | 0.24% | 77 |
|
|
2019
Q4 | $14.7M | Buy |
197,545
+520
| +0.3% | +$36.5K | 0.23% | 74 |
|
|
2019
Q3 | $12.4M | Sell |
197,025
-3,665
| -2% | -$217K | 0.21% | 80 |
|
|
2019
Q2 | $10.9M | Buy |
200,690
+12,423
| +7% | +$669K | 0.18% | 92 |
|
|
2019
Q1 | $10.2M | Sell |
188,267
-4,552
| -2% | -$281K | 0.18% | 91 |
|
|
2018
Q4 | $12.6M | Buy |
192,819
+44,351
| +30% | +$3.31M | 0.25% | 71 |
|
|
2018
Q3 | $11.7M | Sell |
148,468
-5,389
| -4% | -$385K | 0.2% | 86 |
|
|
2018
Q2 | $9.9M | Sell |
153,857
-4,393
| -3% | -$290K | 0.16% | 111 |
|
|
2018
Q1 | $9.84M | Buy |
158,250
+1,145
| +0.7% | +$82.2K | 0.14% | 112 |
|
|
2017
Q4 | $11.4M | Buy |
+157,105
| New | +$11.4M | 0.15% | 91 |
|
|
2017
Q3 | – | Sell |
-494,028
| Closed | -$39.7M | – | 2481 |
|
|
2017
Q2 | $39.7M | Sell |
494,028
-58,591
| -11% | -$4.63M | 0.27% | 64 |
|
|
2017
Q1 | $43.4M | Sell |
552,619
-27,368
| -5% | -$2.18M | 0.3% | 56 |
|
|
2016
Q4 | $45.8M | Sell |
579,987
-12,817
| -2% | -$1.04M | 0.33% | 53 |
|
|
2016
Q3 | $52.8M | Sell |
592,804
-10,959
| -2% | -$1.03M | 0.39% | 48 |
|
|
2016
Q2 | $57.8M | Sell |
603,763
-20,900
| -3% | -$2.08M | 0.43% | 45 |
|
|
2016
Q1 | $64.8M | Sell |
624,663
-14,908
| -2% | -$1.45M | 0.5% | 39 |
|
|
2015
Q4 | $62.5M | Sell |
639,571
-6,290
| -1% | -$616K | 0.48% | 40 |
|
|
2015
Q3 | $62.3M | Sell |
645,861
-18,306
| -3% | -$1.92M | 0.45% | 40 |
|
|
2015
Q2 | $69.7M | Buy |
664,167
+40,130
| +6% | +$4.1M | 0.49% | 35 |
|
|
2015
Q1 | $64.4M | Sell |
624,037
-19,354
| -3% | -$1.96M | 0.47% | 37 |
|
|
2014
Q4 | $62M | Sell |
643,391
-27,478
| -4% | -$2.42M | 0.43% | 43 |
|
|
2014
Q3 | $53.4M | Sell |
670,869
-15,923
| -2% | -$1.26M | 0.38% | 46 |
|
|
2014
Q2 | $51.8M | Sell |
686,792
-41,660
| -6% | -$3.15M | 0.36% | 49 |
|
|
2014
Q1 | $54.5M | Sell |
728,452
-15,679
| -2% | -$1.11M | 0.38% | 44 |
|
|
2013
Q4 | $53.3M | Sell |
744,131
-38,028
| -5% | -$2.44M | 0.37% | 50 |
|
|
2013
Q3 | $44.4M | Sell |
782,159
-1,886
| -0.2% | -$112K | 0.34% | 53 |
|
|
2013
Q2 | $44.8M | Buy |
+784,045
| New | +$45.4M | 0.36% | 49 |
|
Other funds holding CVS
Metropolitan Life Insurance Company (MetLife)'s CVS Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of CVS Health (CVS) in Q2 2024, closing a stake of 50,757 shares — an estimated $4.05M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in CVS in Q2 2013 and held it in 43 quarters. The position peaked at $69.7M in Q2 2015. 1,912 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 50,757 CVS Health shares in Q2 2024, an estimated $4.05M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in CVS Health in Q2 2013 and held it in 43 quarters.
- Metropolitan Life Insurance Company (MetLife)'s CVS Health position peaked at $69.7M in Q2 2015.
- 1,912 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.